A Multicenter, Randomized, Double-Blind, Parallel Group, 52-Week Comparison of Asthma Control and Measures of Airway Inflammation in Subjects of African Descent Receiving Fluticasone Propionate/Salmeterol 100/50mcg DISKUS BID or Fluticasone Propionate 100mcg DISKUS BID Alone
Phase of Trial: Phase IV
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Jun 2008 Primary endpoint not met, reported by GlaxoSmithKline.
- 10 Jun 2008 Results reported in Current Medical Research and Opinion in June 2008, according to a GlaxoSmithKline media release.
- 14 Jan 2008 Status changed from in progress to completed according to ClinicalTrials.gov.